Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
TuHURA Biosciences, Inc.
Market Cap
$120.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$120.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$122.74M
Operating Margin
-1324.41%
TTM Avg
-662.21%
3Y Avg
-331.10%
5Y Avg
-220.74%
Market Cap
$123.66M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
Market Cap
$124.95M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$116.80M
Operating Margin
-477.46%
TTM Avg
-238.73%
3Y Avg
-136.84%
5Y Avg
-91.23%
Market Cap
$116.54M
Operating Margin
-1220.49%
TTM Avg
-1443.83%
3Y Avg
-998.11%
5Y Avg
-830.42%
Market Cap
$117.86M
Operating Margin
-754.08%
TTM Avg
-1999.61%
3Y Avg
-1887.55%
5Y Avg
-2072.97%
Market Cap
$114.62M
Operating Margin
-137.12%
TTM Avg
-134.83%
3Y Avg
-112.12%
5Y Avg
-90.73%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $120.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $122.74M | -1324.41% | -662.21% | -331.10% | -220.74% |
| Cibus, Inc. (CBUS)vs › | $123.66M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| Entera Bio Ltd. (ENTX)vs › | $124.95M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.80M | -477.46% | -238.73% | -136.84% | -91.23% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.54M | -1220.49% | -1443.83% | -998.11% | -830.42% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $117.86M | -754.08% | -1999.61% | -1887.55% | -2072.97% |
| MaxCyte, Inc. (MXCT)vs › | $114.62M | -137.12% | -134.83% | -112.12% | -90.73% |
| Genelux Corporation (GNLX)vs › | $114.34M | -415175.00% | -405687.50% | -206404.23% | -137602.82% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
